Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lytus Technologies | LYT | Nov 1, 2024 | 1.70 | -1.16 |
M&T Bank | MTB | Nov 1, 2024 | 192.25 | -1.25 |
M&T Bank ADR Prej J | MTB-J | Nov 1, 2024 | 27.17 | -0.55 |
M&T Bank H Pref | MTB-H | Nov 1, 2024 | 25.35 | -0.20 |
M-tron Industries | MPTI | Nov 1, 2024 | 52.07 | +3.35 |
M/I Homes | MHO | Nov 1, 2024 | 150.23 | -0.90 |
M3-Brigade Acquisition V | MBAVU | Nov 1, 2024 | 10.09 | 0.00 |
M3-Brigade Acquisition V | MBAV | Nov 1, 2024 | 10.02 | 0.00 |
Macerich | MAC | Nov 1, 2024 | 18.32 | -2.03 |
Mach Natural Resources LP | MNR | Nov 1, 2024 | 15.75 | -2.17 |
MACOM Technology Solutions | MTSI | Nov 1, 2024 | 112.65 | +0.22 |
MacroGenics | MGNX | Nov 1, 2024 | 3.87 | +5.74 |
Macy`s | M | Nov 1, 2024 | 15.27 | -0.46 |
Madison Covered Call & Equity Strategy Fund | MCN | Nov 1, 2024 | 6.95 | +1.31 |
Madison Square Garden Entertainment | MSGE | Nov 1, 2024 | 40.92 | -1.89 |
Madison Square Garden Sports A | MSGS | Nov 1, 2024 | 220.99 | -0.77 |
Madrigal Pharmaceuticals | MDGL | Nov 1, 2024 | 319.58 | +23.23 |
MAG Silver | MAG | Nov 1, 2024 | 16.75 | -1.99 |
Magic Empire Global | MEGL | Nov 1, 2024 | 0.51 | -0.22 |
Magic Software Enterprises | MGIC | Nov 1, 2024 | 11.17 | -0.36 |
Magna International | MGA | Nov 1, 2024 | 41.97 | +6.33 |
MagnaChip Semiconductor | MX | Nov 1, 2024 | 3.82 | -13.38 |
Magnite | MGNI | Nov 1, 2024 | 12.41 | -0.56 |
Magnolia Oil & Gas A | MGY | Nov 1, 2024 | 25.00 | -1.11 |
Magyar Bancorp | MGYR | Nov 1, 2024 | 12.22 | -0.81 |
MAIA Biotechnology | MAIA | Nov 1, 2024 | 2.75 | -1.08 |
Maiden Holdings | MHLD | Nov 1, 2024 | 1.56 | +0.97 |
Main Street Capital | MAIN | Nov 1, 2024 | 50.67 | -1.31 |
Mainstay Mackay Definedterm Municipal Opportunities Fund | MMD | Nov 1, 2024 | 16.61 | +0.03 |
MainStreet Bancshares | MNSB | Nov 1, 2024 | 17.27 | -0.03 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.